Professor Jacob George has been appointed as the Medicines and Healthcare products Regulatory Agency’s (MHRA’s) first Chief Medical and Scientific Officer, effective 5 January 2026. In the new post he will lead the agency’s science strategy and oversee its scientific, research and innovation activities. The role was created to reinforce the MHRA’s commitment to scientific excellence and innovation, supporting the UK’s life‑sciences ambitions while safeguarding patient safety. George, formerly Professor of Cardiovascular Medicine and Therapeutics at the University of Dundee and a consultant physician in NHS Tayside, has held senior positions including Co‑Chair of the NIHR Capital Investment Funding Committee and Senior Health Technology Advisor to NICE. He will work with partners across the UK to accelerate access to safe and innovative treatments.
© Crown copyright, 2024, GOV.UK.
Summary adapted from content licensed under the Open Government Licence v3.0.
For details, see https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/.
Original source: https://www.gov.uk/
https://www.gov.uk/government/news/mhra-welcomes-professor-jacob-george-as-he-starts-chief-medical-and-scientific-officer-role
Made by AI. If you spot anything of concern write us at contact@cybach.com. We’ll promptly correct irregularities.